Global Small Nucleic Acid Drug Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Research Summary

Small nucleic acid drugs are a class of therapeutic agents that target specific sequences of RNA or DNA to regulate gene expression and modulate biological processes at the molecular level. These drugs, including antisense oligonucleotides, small interfering RNA (siRNA), and messenger RNA (mRNA) therapeutics, are designed to bind to their target nucleic acids and either block the production of harmful proteins or correct genetic defects. Small nucleic acid drugs have gained significant attention for their potential to treat a wide range of diseases, including genetic disorders, viral infections, and cancer, by precisely targeting the root cause of the disease at the genetic level. These drugs offer a novel and highly specific approach to therapy, with the ability to treat conditions that were previously difficult or impossible to address with traditional small-molecule drugs.

According to DIResearch's in-depth investigation and research, the global Small Nucleic Acid Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size has reached XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global suppliers of Small Nucleic Acid Drug include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Small Nucleic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Small Nucleic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Small Nucleic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Small Nucleic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Small Nucleic Acid Drug Include:

Sarepta Therapeutics

Ionis Pharmaceuticals

Alnylam

Biogen

Nippon Shinyaku

Sobi

Novartis

Jazz Pharmaceuticals

AstraZeneca

Novo Nordisk

Astellas Pharma

Geron Corporation

CureVac

Regulus Therapeutics

ProQR

Secarna

MiNA Therapeutics

Sylentis

Arrowhead

Silence Therapeutics

Small Nucleic Acid Drug Product Segment Include:

Antisense Oligonucleotides (ASO)

siRNA

Others

Small Nucleic Acid Drug Product Application Include:

Neuromuscular Diseases

hATTR

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Small Nucleic Acid Drug Industry PESTEL Analysis

Chapter 3: Global Small Nucleic Acid Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Small Nucleic Acid Drug Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Small Nucleic Acid Drug Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Small Nucleic Acid Drug Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Small Nucleic Acid Drug Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources

Table 1： Small Nucleic Acid Drug Industry Development Status

Table 2： Small Nucleic Acid Drug Industry Development Trends

Table 3： Global Small Nucleic Acid Drug Revenue and Growth Rate (CAGR) by Country: 2024 VS 2025 VS 2032 (US$ Million)

Table 4： Global Small Nucleic Acid Drug Revenue by Country (2020-2025) & (US$ Million)

Table 5： Global Small Nucleic Acid Drug Revenue Market Share by Country (2020-2025)

Table 6： Global Small Nucleic Acid Drug Revenue Forecast by Country (2026-2032) & (US$ Million)

Table 7： Global Small Nucleic Acid Drug Revenue Market Share Forecast by Country (2026-2032)

Table 8： Global Small Nucleic Acid Drug Market Revenue by Key Suppliers (2021-2025) & (US$ Million)

Table 9： Global Small Nucleic Acid Drug Revenue Market Share by Key Suppliers (2021-2025)

Table 10： Global Key Suppliers Headquarter and Key Area Sales

Table 11： Market Mergers & Acquisitions, Expansion

Table 12： Global Small Nucleic Acid Drug Market Size and Growth Rate (CAGR) Analysis by Type: 2024 VS 2025 VS 2032 (US$ Million)

Table 13： Global Small Nucleic Acid Drug Revenue Analysis by Type (2020-2025) & (US$ Million)

Table 14： Global Small Nucleic Acid Drug Revenue Forecast Analysis by Type (2026-2032) & (US$ Million)

Table 15： Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 16： Sarepta Therapeutics Small Nucleic Acid Drug Product Portfolio

Table 17： Sarepta Therapeutics Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 18： Ionis Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 19： Ionis Pharmaceuticals Small Nucleic Acid Drug Product Portfolio

Table 20： Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 21： Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 22： Alnylam Small Nucleic Acid Drug Product Portfolio

Table 23： Alnylam Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 24： Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 25： Biogen Small Nucleic Acid Drug Product Portfolio

Table 26： Biogen Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 27： Nippon Shinyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 28： Nippon Shinyaku Small Nucleic Acid Drug Product Portfolio

Table 29： Nippon Shinyaku Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 30： Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 31： Sobi Small Nucleic Acid Drug Product Portfolio

Table 32： Sobi Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 33： Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 34： Novartis Small Nucleic Acid Drug Product Portfolio

Table 35： Novartis Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 36： Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 37： Jazz Pharmaceuticals Small Nucleic Acid Drug Product Portfolio

Table 38： Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 39： AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 40： AstraZeneca Small Nucleic Acid Drug Product Portfolio

Table 41： AstraZeneca Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 42： Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 43： Novo Nordisk Small Nucleic Acid Drug Product Portfolio

Table 44： Novo Nordisk Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 45： Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 46： Astellas Pharma Small Nucleic Acid Drug Product Portfolio

Table 47： Astellas Pharma Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 48： Geron Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 49： Geron Corporation Small Nucleic Acid Drug Product Portfolio

Table 50： Geron Corporation Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 51： CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 52： CureVac Small Nucleic Acid Drug Product Portfolio

Table 53： CureVac Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 54： Regulus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 55： Regulus Therapeutics Small Nucleic Acid Drug Product Portfolio

Table 56： Regulus Therapeutics Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 57： ProQR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 58： ProQR Small Nucleic Acid Drug Product Portfolio

Table 59： ProQR Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 60： Secarna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 61： Secarna Small Nucleic Acid Drug Product Portfolio

Table 62： Secarna Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 63： MiNA Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 64： MiNA Therapeutics Small Nucleic Acid Drug Product Portfolio

Table 65： MiNA Therapeutics Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 66： Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 67： Sylentis Small Nucleic Acid Drug Product Portfolio

Table 68： Sylentis Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 69： Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 70： Arrowhead Small Nucleic Acid Drug Product Portfolio

Table 71： Arrowhead Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 72： Silence Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 73： Silence Therapeutics Small Nucleic Acid Drug Product Portfolio

Table 74： Silence Therapeutics Small Nucleic Acid Drug Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 75： Global Small Nucleic Acid Drug Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032 & (US$ Million)

Table 76： Global Small Nucleic Acid Drug Revenue Analysis by Application (2020-2025) & (US$ Million)

Table 77： Global Small Nucleic Acid Drug Revenue Forecast Analysis by Application (2026-2032) & (US$ Million)

Table 78： Small Nucleic Acid Drug Typical Customer List

Table 79： Small Nucleic Acid Drug Distributors List

Figure 1： Small Nucleic Acid Drug Product Pictures

Figure 2： Antisense Oligonucleotides (ASO) Picture Scope

Figure 3： siRNA Picture Scope

Figure 4： Others Picture Scope

Figure 5： Neuromuscular Diseases Picture Scope

Figure 6： hATTR Picture Scope

Figure 7： Others Picture Scope

Figure 8： Global Small Nucleic Acid Drug Market Size Analysis：2024 VS 2025 VS 2032 (US$ Million)

Figure 9： Global Small Nucleic Acid Drug Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)

Figure 10： Global Small Nucleic Acid Drug Revenue Market Share by Country in 2024

Figure 11： United States Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 12： Germany Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 13： Japan Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 14： China Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 15： France Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 16： U.K. Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 17： South Korea Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 18： Canada Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 19： Italy Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 20： Russia Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 21： Mexico Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 22： Brazil Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 23： India Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 24： Vietnam Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 25： Thailand Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 26： South Africa Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 27： Global Small Nucleic Acid Drug Revenue Market Share by Key Suppliers in 2024

Figure 28： Global Small Nucleic Acid Drug Industry Competition Landscape

Figure 29： Global Small Nucleic Acid Drug Market Size by Type 2020-2032 (US$ Million)

Figure 30： Global Small Nucleic Acid Drug Market Share by Type: 2025 & 2032

Figure 31： Small Nucleic Acid Drug Industry Chain Analysis

Figure 32： Global Small Nucleic Acid Drug Revenue Market Share by Application (2020-2032)

Figure 33： Key Interview Objectives

Figure 34： Bottom-Up and Top-Down Research Methods